Clik here to view.
Celltrion Begins Global Phase 3 Clinical Trial for Its Bevacizumab Biosimilar...
INCHEON, South Korea Celltrion, Inc. (KRX:068270) is set to launch global Phase 3 clinical trial for its bevacizumab biosimilar ‘CT-P16’ for the treatment of cancer. Celltrion successfully completed...
View ArticleClik here to view.
Samsung Bioepis to Initiate Phase 1 Clinical Trial of SB26 Ulinastatin-Fc...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced it will soon begin a Phase 1 study to evaluate SB26 in healthy volunteers. SB26, also known as TAK-671, is a ulinastatin-Fc (UTI-Fc) fusion...
View ArticleClik here to view.
GI Dynamics Announces FDA Approval for EndoBarrier Pivotal Trial
BOSTON & SYDNEY GI Dynamics Inc. (ASX:GID): • Primary Endpoint Reduction of HbA1c at 1 year • Planned Study Size Stage I: 50 EndoBarrier / 17 control Stage II (upon FDA approval): 130...
View ArticleClik here to view.
New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse...
SOUTHAMPTON, England Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful...
View ArticleClik here to view.
ソウルバイオシス、UV LEDの新製品”UV WICOP”を発売
韓国安山市 （ビジネスワイヤ） — Seoul Viosys Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウルバイオシス」)は、ソウル半導体の超小型/高効率パッケージレスLEDの「WICOP」技術を取り入れた製品となるUV WICOPの販売を開始したと発表した。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：...
View ArticleClik here to view.
首尔伟傲世推出UV LED新产品“UV WICOP”
韩国 安山 (美国商业资讯)–首尔伟傲世(SEOUL VIOSYS,首尔半导体子公司)发布,推出结合首尔半导体微型高效率LED“WICOP”技术的新产品“UV WICOP”。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20180813005212/zh-CN/ Seoul Viosys’s UV WICOP...
View ArticleClik here to view.
ダウン症候群の小児を対象とする睡眠時障害診断のマルチチャンネル研究に先立つ閉塞性睡眠時無呼吸症リスクのスクリーニングとしてMasimo...
英サウサンプトン （ビジネスワイヤ）– マシモ（NASDAQ:...
View ArticleClik here to view.
新研究调查诊断性多通道睡眠检查之前采用Masimo SET®脉搏氧饱和度仪居家监测筛查唐氏综合征患儿罹患阻塞性睡眠呼吸暂停的风险
英格兰南安普顿 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了最近发表的一项研究结果，该研究中，研究人员调查居家脉搏氧饱和度仪监测能否作为有用的初步筛查方法，用于确定推荐哪些唐氏综合征(DS)患儿通过多通道睡眠检查来诊断该病，DS患儿是阻塞性睡眠呼吸暂停(OSA)的高危人群。居家监测采用的是Masimo SET®移动和低灌注下测量(Measure-through...
View ArticleClik here to view.
STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of...
View ArticleClik here to view.
AVEO Announces Acceptance of CANbridge Investigational New Drug Application...
CAMBRIDGE, Mass. AVEO Oncology (Nasdaq: AVEO) today announced that the China National Drug Administration (CNDA) has accepted CANbridge Life Sciences’ Investigational New Drug (IND) Application for...
View ArticleClik here to view.
CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in...
BEIJING CANbridge Life Sciences, a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that the China National Drug Administration (CNDA) has approved the...
View ArticleClik here to view.
Clik here to view.
Harbour BioMed Announces Global Strategic Partnership with Kelun-Biotech to...
SHANGHAI & CHENGDU, China & BOSTON & CRANBURY, N.J. Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical...
View ArticleClik here to view.
Clik here to view.
Vertex Receives a Positive PBAC Recommendation for Reimbursement of ORKAMBI®...
LONDON Vertex Pharmaceuticals (Europe) Limited announces that it has received the Pharmaceutical Benefits Advisory Committee’s (PBAC) recommendation for ORKAMBI® (lumacaftor/ivacaftor) to be listed...
View ArticleClik here to view.
ABLIC Inc. Launches the S-85M0A Series of Ultra-High Efficiency Step-Down...
CHIBA, Japan ABLIC Inc. (hereinafter “ABLIC”), a semiconductor manufacturer, today launched the S-85M0A Series of ultra-high efficiency step-down switching regulators for wearable and IoT devices....
View ArticleClik here to view.
Evaluate Ltd: Small Drug Developers Continue to Hold All the Cards, While...
LONDON & BOSTON & TOKYO The first half of 2018 has seen biopharma IPOs and venture financing accelerate from the already-healthy levels witnessed in 2017. Deal making has dimmed further,...
View ArticleClik here to view.
Murata Invests in MEMS Sensor Manufacturing in Finland
KYOTO, Japan Murata Manufacturing Co., Ltd. (TOKYO:6981) (ISIN:JP3914400001) expands its MEMS sensor manufacturing by building a new factory in Vantaa, Finland to increase the sensor production...
View ArticleClik here to view.
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin...
KAWASAKI, Japan Therabiopharma, a Japan based bio-venture, reports that CMG(Curcumin Monoglucuronide) has proven: This press release features multimedia. View the full release here:...
View ArticleClik here to view.
ABLIC Inc.推出采用业界最紧凑(*)型封装的S-85M0A系列超高效降压型开关稳压器
日本千叶 (美国商业资讯)–半导体制造商ABLIC Inc.（以下简称“ABLIC”）今日面向可穿戴设备和物联网设备推出S-85M0A系列超高效降压型开关稳压器。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20180821005755/zh-CN/ WLP-6L (Graphic: Business Wire)...
View Article